RWD23 Comparison of the Use of Real-World Evidence (RWE) by Health Technology Assessment (HTA) Agencies in Reviews of Drugs for Rare Diseases (DRDS)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2741
https://www.valueinhealthjournal.com/article/S1098-3015(23)05871-0/fulltext
Title :
RWD23 Comparison of the Use of Real-World Evidence (RWE) by Health Technology Assessment (HTA) Agencies in Reviews of Drugs for Rare Diseases (DRDS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05871-0&doi=10.1016/j.jval.2023.09.2741
First page :
Section Title :
Open access? :
No
Section Order :
12074